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Follicular regulatory T cells can be speciﬁc for the
immunizing antigen and derive from naive T cells
Meryem Aloulou1,2,3, Edward J. Carr4, Myle`ne Gador1,2,3, Alexandre Bignon4, Roland S. Liblau1,2,3,
Nicolas Fazilleau1,2,3,* & Michelle A. Linterman4,*
T follicular regulatory (Tfr) cells are a subset of Foxp3þ regulatory T (Treg) cells that form in
response to immunization or infection, which localize to the germinal centre where they
control the magnitude of the response. Despite an increased interest in the role of Tfr cells in
humoral immunity, many fundamental aspects of their biology remain unknown, including
whether they recognize self- or foreign antigen. Here we show that Tfr cells can be speciﬁc for
the immunizing antigen, irrespective of whether it is a self- or foreign antigen. We show
that, in addition to developing from thymic derived Treg cells, Tfr cells can also arise from
Foxp3 precursors in a PD-L1-dependent manner, if the adjuvant used is one that supports
T-cell plasticity. These ﬁndings have important implications for Tfr cell biology and for
improving vaccine efﬁcacy by formulating vaccines that modify the Tfr:Tfh cell ratio.
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A
fter immunization with T-dependent antigens (Ags),
germinal centres (GC) form in secondary lymphoid
tissues. GCs are clusters of rapidly dividing B cells that
have point mutations introduced into the Ag-binding regions of
their B-cell receptor genes by the process of somatic hypermuta-
tion. The mutated B cells are then subjected to selection, and
often further rounds of mutation, before exiting the GC as
long-lived plasma cells or memory B cells. This process is
dependent on ‘help’ delivered from T follicular helper (Tfh) cells,
a specialized subset of CD4þ T cells1,2. Because of the random
nature of somatic hypermutation, stringent control of the GC is
required to ensure the generation of high-afﬁnity effector cells
that do not react with self-Ags3. The size and speciﬁcity of the GC
is inﬂuenced by a number of factors, including a subset of
suppressive Foxp3þ T follicular regulatory cells, coined Tfr cells4.
Tfr cells were ﬁrst identiﬁed in the GC of human tonsils5 and
their biology was elucidated in mice6–8. These cells are thought to
form after vaccination when Foxp3þ precursors co-opt the Tfh
cell differentiation pathway, acquiring a Tfh-like phenotype that
includes expression of Bcl-6, CXCR5, PD-1 and ICOS. Although
Tfr cells share some features of Tfh cells, Tfr cells do not express
the B-cell helper molecules interleukin (IL)-21, IL-4 and CD40L
that are characteristic of Tfh cells. By contrast, in addition to
Foxp3, Tfr cells express a range of proteins that are typical of
regulatory T (Treg) cells, such as GITR, Blimp-1 and CTLA-4
(refs 6–8). Control of Tfr cell differentiation utilizes molecular
pathways that are both common to, and distinct from, Tfh cells,
including the expression of Helix–Loop–Helix proteins Id2 and
Id3 to limit Tfr cell formation9 and NFAT to facilitate CXCR5
upregulation on Foxp3þ T cells10, a function of Ascl-2 in Tfh
cells11. This change in chemokine receptor expression allows Tfr
cells to migrate into the B-cell follicle where they act as
suppressor cells within the GC. Tfr cells control the magnitude
of the GC response after immunization through molecules such
as CTLA-4 (refs 12,13). They have also been implicated in the
control of humoral autoimmunity in mice6–8,10,14.
One of the key unknowns of Tfr cell biology is the Ag
speciﬁcity of these cells. It is clear that Tfr cells have common
features with Tfh cells that are speciﬁc for the immunizing
Ag15,16, but also with Treg cells, a T-cell population that has a
T-cell receptor (TCR) repertoire skewed towards recognition of
self-Ags17–19. The observation that Tfr cells derive from Foxp3þ
precursors and that Tfr cells do not arise from TCR-transgenic
CD4þ T cells speciﬁc for an immunizing Ag6–8 prompted the
hypothesis that Tfr cells are speciﬁc for self-Ag.
Here, we examined the Ag speciﬁcity of Tfr cells using
peptide:MHC (major histocompatibility complex) class II
(pMHCII) tetramers for both self and foreign Ag after
immunization. Our results show that Tfr cells are speciﬁc for
the immunizing Ag, irrespective of whether it is self or foreign
Ag. To our surprise, this research also revealed that Tfr cells can
derive from Treg cells that are induced in the periphery (pTreg)
in addition to thymic derived Treg cells (tTreg), a process that
required PD-L1 signalling.
Results
Tfr and Tfh cells are speciﬁc for the immunizing Ag. Since the
TCR repertoire of Tfr cells could be largely skewed towards
self-Ag, we took advantage of two different tools to formally
investigate Ag speciﬁcity of Tfr cells after immunization. The ﬁrst,
pMHCII tetramers, which allows the detection of CD4þ T cells
speciﬁc for the immunodominant peptide (MOG35-55) of the
self-Ag myelin oligodendrocyte glycoprotein (MOG) in the
context of I-Ab in wild-type (WT) C57BL/6 mice. The second,
nefm /mog / mouse model (referred to here as Dko)
deﬁcient for the self-Ag MOG and the neuronal cytoskeletal
neuroﬁlament-M that thus provides an experimental system in
which MOG35-55 can be considered a foreign Ag20. With no
immunization, we found almost no pMHCII tetramerþ CD4þ
T cells, either Foxp3 or Foxp3þ , in the inguinal and periaortic
lymph nodes (LNs) of both WT and Dko mice (Fig. 1a and
Supplementary Fig. 1); this is consistent with the ﬁndings of
Jenkins and colleagues who demonstrated that there are B250
tetramer-binding CD4þ T cells per mouse in the steady
state21,22. We then examined this I-Ab-restricted murine T-cell
response in the draining LN (dLN) after subcutaneous (s.c.)
immunization with MOG35-55 emulsiﬁed in Complete Freund’s
Adjuvant (CFA). Using an irrelevant pMHCII tetramer (the I-Ab
human CLIP 87-101), no tetramerþ cells were detected in
unimmunized and 1W1K-immunized mice (Fig. 1a). In contrast,
we detected a population of CD44þ and MOG35-55-I-Ab
tetramerþ MOG-speciﬁc CD4þ T cells in the dLN of both
WT and Dko mice 7 days post immunization with MOG35-55 in
CFA (Fig. 1a). As expected, in WT mice having MOG as a
self-Ag, the frequency of MOG-speciﬁc CD4þ T cells was
reduced compared with Dko mice having MOG35-55 as a foreign
Ag (Fig. 1a, 1.47±0.12% versus 0.46±0.04%, Po0.05). Likewise,
the number of Ag-speciﬁc Tfh cells (CD4þ CD44þ MOG38-49-
I-Abþ CXCR5þ PD-1þ Foxp3 ) was reduced in frequency and
in total cell number in WT mice compared with Dko mice
(Fig. 1b,c). On the basis of previous observations that Tfr cells
derive from Treg precursors6–8, we hypothesized that Tfr cells
would be speciﬁc for self-Ag. Surprisingly, both WT and Dko
mice have comparable numbers of Tfr cells (CD4þ CD44þ
MOG38-49-I-Abþ CXCR5þ PD-1þ Foxp3þ ) that are speciﬁc
for MOG35-55, the immunizing Ag (Fig. 1c). Likewise, the
frequency of MOG35-55-speciﬁc T cells (MOG38-49-I-Abþ )
among total Tfr cells (CD4þ CXCR5þ PD-1þ Foxp3þ ) was
similar in WT and Dko mice (Supplementary Fig. 2). Strikingly,
the Tfh:Tfr ratios are higher when speciﬁc for non-self-Ag (Dko
mice) as compared with self-Ag. This suggests that self-Ag
preferentially induces Tfr cells over Tfh cells. Together, these
results demonstrate that Tfr cells form in response to the
immunizing Ag and can share Ag speciﬁcity with their Tfh cell
counterparts.
Tfr cells can derive from pTreg cells. This result raised the
possibility that Tfr cells may arise from Treg cells that are induced
in the periphery (pTreg) in response to immunization. Previous
work suggested that Tfr cells arise from Foxp3þ precursors.
Indeed, when naive T cells and CXCR5 Foxp3þ T cells were
co-transferred into T-cell-deﬁcient mice the majority of Tfr cells
derive from Foxp3þ precursors after immunization7,8. Moreover,
depletion of Treg cells at the time of immunization results in the
lack of Tfr cells after the GC has formed, despite the recovery of
total Treg cell numbers at this time point6, suggesting that Tfr
differentiation is initiated at the time of the T-cell priming.
Notably, the majority of previous studies on Tfr cells used one of
three adjuvants, sheep red blood cells, alum and CFA that are not
reported to support pTreg cell generation after immunization. By
contrast, Incomplete Freund’s Adjuvant (IFA) facilitates the
polarization of naive CD4þ T cells to Foxp3þ pTreg cells23. We
included IFA in our analyses along with CFA to determine
whether an adjuvant that can support pTreg generation has an
impact on Tfr cell production.
When WT mice were immunized with MOG35-55 emulsiﬁed
in either IFA or CFA, the proportion and absolute numbers of
MOG-speciﬁc Tfr and Tfh cells were similar on days 5, 7 and 9
after immunization. In contrast, the number of MOG-speciﬁc Tfh
cells was signiﬁcantly higher in CFA-immunized Dko mice than
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in IFA-immunized Dko mice on days 7 and 9 after immunization
(Fig. 2a). Conversely, the absolute number of MOG-speciﬁc Tfr
cells was higher in IFA-immunized Dko mice on day 9 post
immunization when compared with CFA-immunized mice
(Fig. 2a). Likewise, the frequency of MOG35-55-speciﬁc Foxp3þ
T cells (MOG38-49-I-Abþ Foxp3þ ) among follicular T cells
(CD4þ CXCR5þ PD-1þ ) was signiﬁcantly higher in
IFA-immunized Dko mice than in CFA-immunized Dko mice
(Supplementary Fig. 3). Together, this series of data suggests that
IFA supports Tfr cell development, possibly through the
induction of pTreg cells. To examine this in more detail, we
assessed the expression of Neuropilin-1, a cell surface receptor
that is present on tTreg cells and a small number of pTreg cells
generated in highly inﬂammatory environments24,25. Thus, it is
thought that all the Neuropilin-1lo Foxp3þ Treg cells are pTreg
cells. We found that the increase in total MOG-speciﬁc Tfr cells
following immunization in IFA correlated with an increase in the
Neuropilin-1lo Tfr cell population (Fig. 2b). This only occurred
when MOG was a foreign Ag, and not when MOG was a self-Ag
(Fig. 2b). These data support the concept that, when MOG is a
foreign Ag, MOG-speciﬁc Tfr cells can originate from induced
pTreg cells. We tested whether higher induction of Tfr cells after
IFA immunization as compared with CFA immunization
correlates with a difference in the B-cell response. WT and Dko
mice were immunized with MOG35-55 emulsiﬁed in either IFA
or CFA. Twelve days post immunization, we collected dLN and
found that the frequencies of total plasma cells (CD138þ ) and of
GC B cells (CD95þ Bcl6þ ) were similar in WT mice after
IFA or CFA immunization (Fig. 2c,d and Supplementary
Fig. 4). Similarly, the quantities of MOG-speciﬁc IgG in the
sera of immunized WT mice were similar after IFA or CFA
immunization (Fig. 2e). In contrast, plasma cell frequency, the
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Figure 1 | Tfr and Tfh cells are speciﬁc for the immunizing Ag. (a) hCLIP87-101-I-Ab, MOG38-49-I-Ab and Foxp3 staining of CD19CD8aCD4þ dLN
(inguinal and periaortic) cells (see Supplementary Fig. 1) from unimmunized WT and Dko mice (top panels) and from WT and Dko mice 7 days after
immunization with MOG in CFA (bottom panels). (b) WTand Dko mice were immunized with MOG35-55 emulsiﬁed in CFA. dLNs were harvested 7 days
after immunization for the detection of MOG-speciﬁc activated CD4þ Tcells (CD44þ MOG38-49-I-Abþ ) and, among them, the follicular cells (CXCR5þ
PD-1þ ). Within the latter, we identiﬁed Tfr cells (Foxp3þ ) in both WTand Dko mice. (c) The mean absolute numbers of total MOG-speciﬁc Tfh cells and
MOG-speciﬁc Tfr cells over time in dLN after immunization of WT (solid circle) or Dko mice (open circle); error bars represent s.e.m. In a,b the numbers in
the dot plots represent the mean±s.e.m. Data shown are from a single experiment with ﬁve mice per time point and are representative of three
independent experiments. Data were analysed using the non-parametric Mann–Whitney test. *Po0.05; **Po0.01.
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GC B-cell frequency and the MOG-speciﬁc IgG response
were all higher in Dko mice immunized with CFA than with
IFA (Fig. 2c–e). These data show that there is a correlation
between increased number of Tfr cells and a reduced B-cell
response. However, these experiments do not exclude a
differential effect of IFA and CFA on other cell types that
participate in the GC response.
To conﬁrm that our observations were not only a feature of the
MOG-speciﬁc CD4þ T-cell response in the Dko strain, we
extended our studies to another I-Ab-restricted epitope, the
foreign Ag and peptide variant (EAWGALANKAVDKA, called
1W1K peptide hereafter) of the I-E alpha chain (Ea) in C57BL/6
mice26. We followed the 1W1K-speciﬁc CD4þ T cells using the
corresponding pMHCII tetramer in the dLN after immunization
with 1W1K emulsiﬁed either in IFA or CFA. We found almost no
1W1K-I-Ab tetramerþ CD4þ T cells in the inguinal and
periaortic LNs of unimmunized WT mice (Supplementary Fig. 5).
In contrast, we were able to detect 1W1K-speciﬁc Tfh cells
(CD4þ CD44þ 1W1K-IAbþ CXCR5þ PD-1þ Foxp3 ) and
Tfr cells (CD4þ CD44þ 1W1K-IAbþ CXCR5þ PD-1þ
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Figure 2 | Immunization with MOG in IFA induces increased numbers of Tfr cells that are Neuropilin-1lo. Dko mice were immunized with MOG35-55
emulsiﬁed in CFA or IFA. (a) Absolute numbers of total MOG-speciﬁc Tfh cells and Tfr cells of Dko mice immunized with CFA (open circle, as in Fig. 1c) or
IFA (solid circle) at indicated time in dLN. (b) Neuropilin-1lo expression among MOG-speciﬁc Tfr cells 7 days after immunization of WTand Dko mice with
MOG35-55 emulsiﬁed in CFA (white circles) or IFA (black circles). Data shown are from a single experiment (ﬁve mice per group) and are representative of
three independent experiments. (c) CD138 and B220 staining of CD3 CD138þ or B220þ dLN cells (see Supplementary Fig. 4) fromWTand Dko mice 12
days after immunization with MOG in IFA or CFA. (d) CD95 and Bcl6 staining of CD138 B220þ cells. (e) Frequencies of total plasma cells and GC B cells
of WTand Dko mice immunized with IFA (solid circle) and CFA (open circle) in dLN 12 days after MOG immunization. (f) Quantity of MOG-speciﬁc Ig in
the sera of immunized WTand Dko mice estimated using ELISA 12 days after MOG immunization. Data shown are from a single experiment with ﬁve mice
per group and are representative of two independent experiments. Data were analysed using the non-parametric Mann–Whitney test. ns, not signiﬁcant,
*Po0.05, **Po0.01, mean±s.e.m.
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Foxp3þ ) in immunized WT mice (Fig. 3a). The number
of 1W1K-speciﬁc Tfh cells was decreased in IFA-immunized
WT mice as compared with CFA-immunized mice, and
more 1W1K-speciﬁc Tfr cells 9 days post immunization were
found in IFA-immunized mice (Fig. 3b). Likewise, the frequency
of 1W1K-speciﬁc cells (1W1K-IAbþ ) among total Tfr
cells was higher in IFA-immunized WT mice as compared
with CFA-immunized mice (Supplementary Fig. 6). Moreover, as
observed for MOG-speciﬁc Tfr cells in IFA-immunized
Dko mice, a higher proportion of 1W1K-speciﬁc Tfr cells were
Neuropilin-1lo in IFA-immunized mice (Fig. 3c). Together, these
data support the hypothesis that Tfr cells speciﬁc for foreign Ag
can derive from Foxp3 precursors when immunization is
performed with an adjuvant that supports this type of T-cell
plasticity.
Previous work suggested that Tfr cells derive from Foxp3þ
precursors by using a depletion system to remove total Foxp3þ
Treg cells at the time of immunization. In this system, Tfr cell
formation was impaired, suggesting that these cells derive from
Foxp3þ precursors6. However, in light of the data presented
here, an alternate interpretation is that Tfr cells may also derive
from pTreg cells induced within the ﬁrst 48 h following
vaccination. To test this, we took advantage of the DEREG
mouse model in which green ﬂuorescent protein (GFP) and
diphtheria toxin receptor expression is under the control of the
Foxp3 promoter, the transcriptional regulator of Treg cells27.
These mice were immunized with 1W1K emulsiﬁed in IFA and
were treated on the day of immunization and 1 day later with
diphtheria toxin (DTx), which because of its short half-life in vivo
caused the death of tTreg cells and emerging pTreg cells induced
within the ﬁrst 2 days following immunization. Three and ﬁve
days after immunization, we found statistically signiﬁcant
differences in the total number of Foxp3þ CD4þ T cells in
the dLN of the DTx-treated DEREG and WT mice, and conclude
that the Treg cell pool after DTx has not recovered completely at
these time points (Supplementary Fig. 7). Seven days after
immunization, we found no difference in the total number of
Foxp3þ CD4þ T cells in the dLN of the DTx-treated DEREG
and WT mice (Fig. 4a), demonstrating that the Treg cell
population has recovered numerically by this time point. We
observed an increase in 1W1K-speciﬁc Tfh cells in DTx-treated
DEREG as compared with DTx-treated WT mice on day 7
after immunization (Fig. 4a), while this was not seen on day 5
after immunization (Supplementary Fig. 7), suggesting that
dysregulation of Ag-speciﬁc Tfh cells occurs cumulatively over
time in the absence of Treg cells. We hypothesized that this may
correlate with reduced Ag-speciﬁc Tfr cell number. Indeed, very
few 1W1K-speciﬁc Tfr cells could be detected in DTx-treated
DEREG mice compared with DTx-treated WT mice on day 5
(Supplementary Fig. 7) and day 7 after immunization (Fig. 4a).
These data support the hypothesis that Tfr cell differentiation
begins within the ﬁrst 48 h after immunization, from either tTreg
or pTreg cells, and that loss of Treg cells, at the time of
immunization, results in an expansion of the Ag-speciﬁc Tfh
cell pool.
Naı¨ve CD4þ T cells can become Tfr cells. To determine whe-
ther Tfr cells can indeed derive from naive CD4þ T cells, we
developed mixed bone marrow (BM) chimeras in which all T
cells lack CXCR5 expression, into which we could introduce
and track naive CD4þ T cells from DEREG mice (Fig. 4b).
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These CXCR5 T chimeric mice were generated by recon-
stituting irradiated mice with a 75:25% mix of BM from
Zap70 / mice, which do not generate peripheral T cells, and
from Cxcr5 / mice. In these chimeras, all T cells lack CXCR5
and therefore have a competitive disadvantage for accessing the
follicular niche compared with the CXCR5-sufﬁcient CD4þ T
cells introduced from DEREG mice28. This system has the
advantage of transferring cells with a competitive advantage
over endogenous cells while not introducing cells into
lymphopenic hosts. We isolated naive CD4þ T cells devoid of
Foxp3þ cells from DEREG mice (CD19 CD8 CD4þ
CD44lo CD62Lþ GFP ; Supplementary Fig. 8). These
Foxp3 cells were transferred intravenously into the
CXCR5 T chimeras, 8 weeks after reconstitution, followed
by immunization with 1W1K emulsiﬁed in IFA. Seven days
later, dLNs were collected and the 1W1K-speciﬁc CD4þ T-cell
response assessed. Follicular T cells (CD4þ CXCR5þ PD-1þ )
can be found in CXCR5 T chimeras, after transfer of naive
CD4þ T cells (Fig. 4c). Among these follicular T cells, B5%
were speciﬁc for 1W1K. Strikingly, GFPþ cells were detected
among the 1W1K-speciﬁc CD4þ T cells of follicular phenotype
(Fig. 4c). As GFP marks Foxp3 expression only in the cells of
DEREG mouse origin (that were GFP at the time of transfer),
this demonstrates that Tfr cells can arise from naive Foxp3
precursors after IFA immunization. Together, these data
demonstrate that Ag-speciﬁc Tfr cells can derive from naive
CD4þ T cells that are induced to express Foxp3 after
immunization.
PD-L1 promotes the formation of Tfr cells. During T-cell
priming, the interaction between programmed death 1 (PD-1) on
activated T cells and PD-1 ligand (PD-L1) expressed on the Ag-
presenting cells can promote the development and maintenance
of pTreg from naive CD4þ T cells29. Given that PD-1 is
expressed highly by Tfr cells30 and that Tfr cells are induced
within the ﬁrst 48 h after immunization (Fig. 4a), PD-L1
signalling could be implicated in initiating Tfr cell generation
from Foxp3 precursors.
To decipher whether PD-L1 was a mechanism by which Tfr
cells can differentiate from Foxp3 precursors after immuniza-
tion with protein emulsiﬁed in IFA, but not CFA, we ﬁrst assessed
PD-L1 expression at the surface of dendritic cells (DCs). After
immunization with a protein (immunodominant peptide of I-Ea
chain conjugated to ovalbumin) in IFA or CFA, we analysed the
different subsets of DC in the dLN. Among the total DCs
(CD11cþ cells), we found plasmacytoid DC (B220þ ), conven-
tional DCs (either B220 CD8aþ or B220 CD8a CD64 )
and monocyte-derived DCs (moDCs, B220 CD8a CD64þ ;
Fig. 5a). No differential expression of PD-L1 at the surface of
plasmacytoid DC or conventional CD8aþ DC could be detected
after IFA or CFA immunization at 12, 24 or 48 h after
immunization (Supplementary Fig. 9). In contrast, conventional
CD8a DC and moDC expressed high levels of PD-L1 at their
surface at each time points (Supplementary Fig. 9 and Fig. 5b).
Strikingly, while the expression of PD-L1 was similar at the
surface of the conventional CD8a DCs, we found a signiﬁcant
decrease in the geometric mean ﬂuorescence intensity of PD-L1
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expression when comparing moDCs from CFA-immunized
versus IFA-immunized mice at 24 and 48 h after immunization
(Supplementary Fig. 9 and Fig. 5c). This is striking as we have
previously shown that moDCs are the main cells presenting the
Ag through MHCII molecules after protein immunization26. This
result supports the hypothesis that the difference in the number
of Tfr cells that are induced after IFA- and CFA-based
immunization is PD-L1-mediated.
To formally test this hypothesis, we immunized WT mice with
1W1K in IFA and treated them with an anti-PD-L1-blocking
antibody the day of immunization and 2 days later. Seven days
after immunization, we found an increased number of 1W1K-
speciﬁc Tfh cells in the anti-PD-L1-treatment group as compared
with isotype control group (Fig. 5d). The numbers of 1W1K-
speciﬁc Tfr cells were similar in both groups (Fig. 5b), and the
frequency of 1W1K-speciﬁc T cells (1W1K-IAbþ ) among total
Tfr cells (CD4þ Foxp3þ CXCR5þ ) was similar in isotype-
treated versus anti-PD-L1-immunized mice (Supplementary
Fig. 10). In contrast, we observed a signiﬁcant decrease in the
frequency of Neuropilin-1lo cells among the 1W1K-speciﬁc Tfr
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cells after anti-PD-L1 treatment (Fig. 5d), suggesting that PD-L1
supports Tfr cell generation from Foxp3 precursors after
immunization with IFA.
To conﬁrm this observation, we isolated naive CD4þ T cells
(CD19 CD8 CD4þ CD44lo CD25 CD62Lþ ) from
CD45.1/CD45.1 mice and checked that this population was
devoid of Foxp3þ cells (Supplementary Fig. 11). These cells were
then transferred intravenously into CXCR5 T chimeras as
described above (Fig. 4b), followed by immunization with 1W1K
in IFA, and were treated with an anti-PD-L1-blocking antibody
or an isotype control antibody the day of immunization and 2
days later. Seven days later, dLNs were collected and the 1W1K-
speciﬁc CD4þ T-cell response assessed. We found that the
frequencies of 1W1K-speciﬁc CD4þ T cells (CD4þ CD44þ
1W1K-IAbþ ) and, among them, the ones arising from the
transferred cells (CD45.1þ ) were similar between anti-PD-L1 or
isotype-treated mice (Fig. 5e). Strikingly, some of these CD45.1þ
cells were CXCR5þ Foxp3þ in isotype-treated mice, while
almost no transferred cells acquired this phenotype in
anti-PD-L1-treated mice (Fig. 5e). Induced Tfr expressed
higher levels of Bcl6 and PD-1 than their CXCR5 counter-
parts (Supplementary Fig. 12), consistent with these cells
being bona ﬁde Tfr cells. To conﬁrm the presence of these
induced Tfr cells in the GC, we performed immunoﬂuorescence
studies of the dLN and found that, within GL-7þ GCs, CD45.1þ
cells could be identiﬁed, among which 13.60±0.90% were
FoxP3þ (Supplementary Fig. 13). Together, this demonstrates
that naive CD4þ T cells in response to Ag immunization can
become Tfr cells in a PD-L1-dependent manner and localize
to the GC.
Discussion
In this study we have shown that Tfr cells can be speciﬁc for the
immunizing Ag, and that the differentiation of Ag-speciﬁc Tfr
cells is initiated at the time of T-cell priming. Surprisingly, it did
not matter whether the immunizing Ag was a self- or foreign
Ag. We further demonstrate that Tfr cells can derive from
Foxp3 precursors in the context of a stimulus that promotes
the conversion of CD4þ Foxp3 cells into Foxp3þ Treg cells,
speciﬁcally, one that enhances PD-L1 expression on
Ag-presenting cells. Whether these ‘induced’ Tfr cells emerge
from Tfh cells that acquire Foxp3 expression, or from pTreg
cells that acquire the follicular fate through CXCR5 expression,
remains unknown and will need further investigation. However,
Tfh cells cannot be induced to switch on Foxp3 in vitro8,
suggesting that it is more likely that it is pTreg cells that give
rise to Tfr cells.
The Ag speciﬁcity of Tfr cells has been an outstanding question
since their initial characterization. It was initially proposed that
Tfr cells were likely to be speciﬁc for self-Ag because they were
thought to derive exclusively from tTreg6–8. Here we show that a
small proportion of total Tfr cells is speciﬁc for the immunizing
Ag, whether it is a self- or foreign Ag. However, because not all
Tfr cells were speciﬁc for the immunizing Ag, it suggests that
these cells are likely a very heterogeneous population. However,
the speciﬁcity of the Tfr cells not speciﬁc for the immunizing
immunodominant peptide remains elusive. It is worth noting that
in this studyB30% Tfh cells were speciﬁc for the immunizing Ag
as measured using tetramer staining. This suggests that either
there are limitations in these reagents for detecting all cells that
recognize the peptide present on the tetramer, or the speciﬁcity of
the Tfh and Tfr cell populations is considerably more diverse than
that we currently appreciate.
The most unexpected ﬁnding of our study is that we
demonstrate that Tfr cells can derive from Foxp3 precursors.
By using IFA, an adjuvant that promotes pTreg cell formation, we
found that naive CD4þ T cells can become Tfr cells and are
speciﬁc for the immunizing Ag. Generation of Tfr cells from
pTreg cells occurred predominantly when the immunizing Ag
was foreign. We think that this observation may simply reﬂect the
increased precursor frequency of naive CD4þ T cells that are
non-self-reactive, as it would be expected that a large majority of
self-reactive naive T cells would have been removed by thymic
selection.
One other striking observation was the fact that the numbers
of Ag-speciﬁc Tfr cells were similar after anti-PD-L1 treatment
but that we observed a signiﬁcant decrease in the frequency of
Neuropilin-1lo cells among these cells, suggesting that PD-L1
supports Tfr cell generation from Foxp3 precursors after
immunization with IFA. Moreover, we observed that the
number of Ag-speciﬁc Tfh cells was increased in anti-PD-L1
monoclonal antibody-treated mice, and thus in mice with less
Neuropilin-1lo Tfr cells. This could indicate that Neuropilin-1lo
Tfr cells are more efﬁcient than their Neuropilin-1hi Tfr cell
counterparts at controlling the Tfh cell response. Or, alterna-
tively, that inhibiting PD-L1 has a direct effect on Tfh cells
themselves, or another cell type that acts to control the number
of Tfh cells such as regulatory B cells31. This result is in
apparent contrast to that of Sharpe and colleagues who have
shown that inhibiting PD-1 can expand the size of the Tfr cell
population without modifying the Tfh cell pool30. However, in
this study mice were immunized with protein in CFA; thus,
based on the results presented here the number of the
Neuropilin-1lo Tfr cells would be expected to be low. Taken
together, this suggests that PD-L1 may have differential roles in
the induction of Tfr cells depending on whether they arise from
tTreg or pTreg cells.
This study also showed differences in the ratio between
Ag-speciﬁc Tfr and Tfh cells depending on several features. Using
the same immunizing Ag (MOG35-55), we demonstrated that the
Tfr:Tfh cell ratio was higher when this Ag is a self-Ag (in WT
mice) as compared with a foreign Ag (in Dko mice). Moreover,
the Tfr:Tfh cell ratio was also dependent on the adjuvant used.
We found that IFA had a high Tfr:Tfh ratio compared with CFA,
likely because of promoting the peripheral induction of naive
CD4þ T cells into Tfr cells. Taken with our previous study
showing that addition of CpG, a TLR9 agonist, to vaccine
adjuvant improves Tfh cell differentiation26, and with the recent
ﬁndings of Rookhuizen and De Franco32, showing that TLR9
signalling can reduce Tfr cell number, suggests that different
adjuvants could be speciﬁcally chosen to alter the Tfr:Tfh cell
ratio that forms after vaccination to improve efﬁcacy.
Methods
Mice. C57BL/6 mice were purchased from Centre d’Elevage Janvier. C57BL/6
Nefm /Mog / (Dko), C57BL/6 DEREG (gift from T. Sparwasser), C57BL/6
Zap70 / (gift from N. Taylor), C57BL/6 Cxcr5 / (JAX laboratory, stock
number 006659 (ref. 33)), C57BL/6 CD45.1 (gift from S. Guerder) were housed in
our animal facility. Females of 8–12 weeks of age were used for experimental
procedures. All experiments were performed in accordance with national and
European regulations and institutional guidelines. Mouse experimental protocols
were approved by the local ethics committee (Regional approval No. 311155523,
ethical review No. MP/19/58/06/12) or by the UK Home Ofﬁce (PPL 80/2625).
BM chimeras. Mice were g-irradiated (8.5Gy (850 rad), 137Cs source) the day
before intravenous injection of 2 106 T-cell-depleted BM cells. BM cells were
recovered from the femur and tibia. After red cell lysis using Tris-buffered
ammonium chloride, cells were enriched in lineagenegative cells using the mouse
Lineage Cell Depletion kit (Miltenyi Biotec) according to the manufacturer’s
instructions26.
Immunization. IFA and CFA were from Sigma-Aldrich, and 1W1K (EAWGA-
LANKAVDKA), MOG 35-55 (MEVGWYRSPFSRVVHLYRNGK) and Ea-OVA
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(ASFEAQGALANIAVDKA-OVA) from Genecust. Mice were immunized s.c. on
each side at the base of the tail with 50 mg of peptide (1W1K or MOG) or 100 mg of
Ea-OVA in the indicated adjuvant.
Antibodies. For in vivo treatment, intravenous injections of 100 mg 10F.9G2
monoclonal antibody (anti-PD-L1, BioXcell, SKU: BE0101) or Rat IgG2b isotype
control (SKU: BE0090) were performed at days 0 and þ 2 post immunization.
Flow cytometry. For population analysis, dLNs (inguinal and periaortic) of
immunized mice were removed. For staining of Ag-speciﬁc cells, 1W1K-IAb and
MOG38-49-IAb tetramers were obtained from the NIH Tetramer core facility.
Overall, 1 108 cells per ml cells were ﬁrst stained at room temperature for
120min with an optimal concentration of each tetramer (0.007mgml 1 for
1W1K-IAb and 0.036mgml 1 for MOG38-49-IAb and human CLIP87-101-IAb).
Then, cells were incubated on ice for 45min with ﬂuorophore-labelled monoclonal
antibodies. The following monoclonal antibodies purchased from BD Biosciences
were used: anti-CXCR5 (2G8, dilution 1/50), anti-CD8a (53-6.7, dilution 1/400),
anti-CD19 (1D3, dilution 1/400), anti-CD138 (281-2, dilution 1/200), anti-CD45.1
(A20, dilution 1/400), GL-7 (dilution 1/100), anti-CD95 (Jo2, dilution 1/100), anti-
Bcl6 (K112-91, dilution 1/50) and anti-CD64 (X54-5/7.1, dilution 1/200). The
following monoclonal antibodies purchased from eBioscience were used: anti-B220
(RA3-6B2, dilution 1/200), anti-CD4 (RM4-5, dilution 1/400), anti-PD-1 (J43,
dilution 1/200), anti-Foxp3 (FJK-16 s, dilution 1/100), anti-CD44 (IM7, dilution 1/
800) and anti-CD11c (N418, dilution 1/200). Anti-Neuropilin-1 (761705, dilution
1/400) was from R&D. Anti-PD-L1 (10F.9G2, dilution 1/200) was from Biolegend.
For intracellular staining, cell suspensions were ﬁxed and permeabilized using the
BD Fixation/Permeabilization kit (Cat#555028). Before permeabilization, cells were
stained with Fixable Viability Dye eFluor506 (eBioscience, Cat#65-0866). Labelled
cells were acquired and analysed using an LSRII ﬂow cytometer (BD Biosciences,
San Jose, CA) and FlowJo software (Tree Star, Ashland, OR). Doublets and dead
cells were excluded using appropriate FSC/SSC gates.
ELISA. MOG-speciﬁc IgG was detected in the plasma from blood with ELISA
using the SensoLyte Anti-MOG(35-55) IgG Quantitative ELISA Kit (Anaspec, Cat#
AS-54465) as described by the manufacturer.
Statistical analysis. Differences between variables were evaluated using the non-
parametric Mann–Whitney test. All statistical analyses were carried out with the
Prism 4.0 software (GraphPad). P values less than 0.05 were considered statistically
signiﬁcant.
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